Erlotinib Tablets

Erlotinib Tablets

Categories : Oncology

Product Packaging : 30 in HDPE

Product Composition : 25mg, 100mg, 150mg

Erlotinib tablets are targeted anti-cancer medicines classified as epidermal growth factor receptor (EGFR) inhibitors, mainly used in the treatment of non-small cell lung cancer and pancreatic cancer. The formulation works by blocking EGFR pathways that promote tumor cell growth and spread, helping to control disease progression.

Genliva Wellness LLP, operating from Himatnagar, India, supplies Erlotinib tablets for export markets with a focus on oncology therapeutics. The company serves pharmaceutical importers, oncology distributors, and institutional buyers seeking a reliable source of targeted cancer therapy medicines with consistent quality and supply support.

Send Message

Erlotinib tablets are targeted anti-cancer medicines classified as epidermal growth factor receptor (EGFR) inhibitors, mainly used in the treatment of non-small cell lung cancer and pancreatic cancer. The formulation works by blocking EGFR pathways that promote tumor cell growth and spread, helping to control disease progression.

Genliva Wellness LLP, operating from Himatnagar, India, supplies Erlotinib tablets for export markets with a focus on oncology therapeutics. The company serves pharmaceutical importers, oncology distributors, and institutional buyers seeking a reliable source of targeted cancer therapy medicines with consistent quality and supply support.

  • Erlotinib tablets formulated for EGFR-targeted cancer therapy
  • Suitable for oncology distributors and specialty pharmaceutical buyers
  • Designed for use in advanced-stage cancer treatment protocols
  • Manufactured for export supply with consistent batch quality
  • Offered for international markets with flexible packaging options
  • Included in a comprehensive oncology product line from an India-based supplier
  • Treatment of non-small cell lung cancer (NSCLC)
  • Used in pancreatic cancer in combination therapy
  • Applicable in EGFR mutation-positive cancer cases
  • Supports targeted therapy in advanced and metastatic conditions
  • Oral tablet dosage enabling outpatient cancer treatment
  • Reduces dependency on injectable chemotherapy administration
  • Suitable for long-term therapy and continuous dosing schedules
  • Efficient for global distribution and pharmaceutical export logistics

whatsapp-app